The Klebsiella pneumoniae infections market is expanding due to rising prevalence of drug-resistant strains, increased use of rapid diagnostic tools, and development of novel therapeutics including phage therapy and monoclonal antibodies. https://www.datamintelligence.com/research-report/klebsiella-pneumoniae-infections-market